| Percentage of heavy drinking days following Psilocybin-Assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial MP Bogenschutz, S Ross, S Bhatt, T Baron, AA Forcehimes, E Laska, ... JAMA psychiatry 79 (10), 953-962, 2022 | 286 | 2022 |
| Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease AG Fitzmaurice, SL Rhodes, A Lulla, NP Murphy, HA Lam, KC O’Donnell, ... Proceedings of the National Academy of Sciences 110 (2), 636-641, 2013 | 225 | 2013 |
| β-Catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors TD Gould, H Einat, KC O'Donnell, AM Picchini, RJ Schloesser, HK Manji Neuropsychopharmacology 32 (10), 2173-2183, 2007 | 167 | 2007 |
| The behavioral actions of lithium in rodent models: leads to develop novel therapeutics KC O’Donnell, TD Gould Neuroscience & Biobehavioral Reviews 31 (6), 932-962, 2007 | 158 | 2007 |
| Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium TD Gould, KC O'Donnell, AM Picchini, HK Manji Neuropsychopharmacology 32 (6), 1321-1333, 2007 | 120 | 2007 |
| Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test TD Gould, KC O'Donnell, ER Dow, J Du, G Chen, HK Manji Neuropharmacology 54 (3), 577-587, 2008 | 118 | 2008 |
| WldS and PGC-1α regulate mitochondrial transport and oxidation state after axonal injury KC O'Donnell, ME Vargas, A Sagasti Journal of Neuroscience 33 (37), 14778-14790, 2013 | 109 | 2013 |
| Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity KC O’Donnell, A Lulla, MC Stahl, ND Wheat, JM Bronstein, A Sagasti Disease models & mechanisms 7 (5), 571-582, 2014 | 98 | 2014 |
| Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out mice TD Gould, KC O’Donnell, AM Picchini, ER Dow, G Chen, HK Manji Behavioural brain research 189 (1), 117-125, 2008 | 93 | 2008 |
| Dynamics of degeneration and regeneration in developing zebrafish peripheral axons reveals a requirement for extrinsic cell types R Villegas, SM Martin, KC O’Donnell, SA Carrillo, A Sagasti, ML Allende Neural development 7 (1), 1-14, 2012 | 84 | 2012 |
| Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial CL Raison, G Sanacora, J Woolley, K Heinzerling, BW Dunlop, RT Brown, ... JAMA 330 (9), 843-853, 2023 | 77 | 2023 |
| Neurotoxicity of the Parkinson disease-associated pesticide ziram is synuclein-dependent in zebrafish embryos A Lulla, L Barnhill, G Bitan, MI Ivanova, B Nguyen, K O’Donnell, MC Stahl, ... Environmental health perspectives 124 (11), 1766-1775, 2016 | 76 | 2016 |
| Antidepressant‐like responses to lithium in genetically diverse mouse strains A Can, RA Blackwell, SC Piantadosi, DT Dao, KC O'Donnell, TD Gould Genes, Brain and Behavior 10 (4), 434-443, 2011 | 72 | 2011 |
| Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway TD Gould, ER Dow, KC O'Donnell, G Chen, HK Manji CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2007 | 49 | 2007 |
| Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment … SK Podrebarac, KC O'Donnell, SE Mennenga, LT Owens, TC Malone, ... Spirituality in Clinical Practice 8 (3), 177, 2021 | 17 | 2021 |
| Psilocybin for depression: Considerations for clinical trial design KC O’Donnell, SE Mennenga, MP Bogenschutz Journal of Psychedelic Studies 3 (3), 269-279, 2019 | 12 | 2019 |
| Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial KC O'Donnell, SE Mennenga, LT Owens, SK Podrebarac, T Baron, ... Contemporary Clinical Trials 123, 106976, 2022 | 7 | 2022 |
| Mapping consent practices for outpatient psychiatric use of ketamine DS Mathai, SM Lee, V Mora, KC O'Donnell, A Garcia-Romeu, EA Storch Journal of Affective Disorders 312, 113-121, 2022 | 6 | 2022 |
| Letter to the Editor: What Is in a Name? The Many Meanings of “Psychedelic” KC O'Donnell, DE Roberts, THW Ching, G Glick, N Goldway, N Gukasyan, ... Psychedelic Medicine, 2023 | 3 | 2023 |
| The conundrum of therapeutic intoxication DS Mathai, DB Yaden, KC O'Donnell The British Journal of Psychiatry 221 (2), 496-497, 2022 | 2 | 2022 |
Alyssa Picchini SchafferSimons FoundationVerified email at simonsfoundation.org
